Understanding Insurance Formulary Tiers and PA Requirements (2026)
A clear explanation of how insurance formulary tiers work, what preferred vs. non-preferred status means for PA requirements, and how practice managers can navigate tier exceptions to reduce patient costs.
How Formulary Tiers Work
A formulary is the list of medications that an insurance plan covers, organized into tiers that determine patient cost-sharing. Most commercial plans use a four- or five-tier structure. Tier 1 contains preferred generics with the lowest copays, typically $5-$15. Tier 2 contains preferred brand-name drugs at moderate copays of $25-$50. Tier 3 holds non-preferred brands at higher copays of $50-$100. Tier 4 (sometimes called the specialty tier) covers specialty medications, often with coinsurance of 20-33% rather than a flat copay.
Some plans add a Tier 5 for ultra-high-cost specialty drugs or a Tier 0 for preventive medications with $0 copay. Medicare Part D plans must follow CMS-defined tier structures but have flexibility in which drugs they place on each tier. Medicaid plans typically have a simpler preferred/non-preferred structure with minimal cost-sharing for beneficiaries.
The placement of a drug on a particular tier is determined by the Pharmacy and Therapeutics (P&T) committee, which considers clinical evidence, safety, and — critically — the rebate the payer negotiates with the manufacturer. A clinically equivalent drug may be preferred or non-preferred purely based on the rebate deal, which is why formularies change frequently and why checking the current formulary before prescribing is essential.
Preferred vs. Non-Preferred: What It Means for Prior Authorization
Preferred drugs on Tier 1 or Tier 2 typically do not require prior authorization. A prescription for a Tier 1 generic will process at the pharmacy without payer intervention in most cases. Tier 2 preferred brands may require PA for certain quantities or indications but are generally streamlined.
Non-preferred drugs on Tier 3 almost always require prior authorization or a formulary exception request. The payer wants documentation that the preferred alternative was tried first or is clinically inappropriate. Specialty tier drugs on Tier 4 and above nearly universally require PA, regardless of preferred status, due to their cost.
The practical implication for practices is clear: whenever possible, prescribe the preferred formulary agent first. When the clinical situation demands a non-preferred drug, prepare the PA documentation before or simultaneously with the prescription to avoid delays. RxCheckUp checks formulary status in real time and alerts the prescriber when a non-preferred drug is selected, along with the preferred alternative and the specific PA criteria.
The Formulary Exception Process
When a patient needs a non-formulary drug (one not listed on the formulary at all) or a non-preferred drug, clinicians can submit a formulary exception request. This is a specific type of prior authorization that asks the payer to either cover the drug or move it to a lower cost-sharing tier.
A successful formulary exception requires demonstrating that the formulary alternatives are clinically inappropriate for this patient. Acceptable reasons include prior trial and failure of the formulary alternative, contraindication to the formulary alternative (documented allergy, drug interaction, organ dysfunction), or that the formulary alternative is expected to be ineffective based on the patient's condition or pharmacogenomic profile.
The documentation requirements are the same as any PA: specific prior therapy dates, doses, and outcomes; clinical rationale citing guidelines and evidence; and the payer's own policy language. The difference is that a formulary exception explicitly asks the payer to deviate from its standard formulary, so the clinical justification must be particularly strong.
Cost Implications and Tiering Exceptions
Tier placement has direct financial impact on patients. A drug on Tier 4 specialty with 30% coinsurance can cost a patient $500-$2,000 per month out of pocket, while the same drug on Tier 2 might cost $40. For patients on high-deductible health plans, the tier determines the price they pay until the deductible is met — and specialty tier costs count toward the deductible at the full negotiated rate.
Tiering exceptions are an underused tool that can move a drug from a higher tier to a lower one without changing the drug itself. Medicare Part D plans are required to offer tiering exceptions. Commercial plans may offer them voluntarily. To request a tiering exception, the clinician must demonstrate that the patient cannot afford the current tier cost-sharing and that the lower-tier alternatives are clinically inappropriate.
Practice managers and PA coordinators should track tiering exception availability across their top payers and proactively submit tiering exception requests for patients on specialty tier medications who have demonstrated financial hardship. This is one of the highest-impact administrative interventions for patient retention and adherence.
How RxCheckUp Navigates Formulary Complexity
RxCheckUp maintains a continuously updated database of payer formularies, tier structures, and PA requirements. When a clinician selects a medication, the platform immediately displays the tier status, estimated patient cost, preferred alternatives, and any PA or step therapy requirements for that patient's specific plan.
If a non-preferred or non-formulary drug is needed, RxCheckUp generates the formulary exception request with the required clinical documentation, payer-specific policy references, and prior therapy evidence. For tiering exception-eligible plans, the platform flags the opportunity and drafts the request automatically. The goal is to remove formulary complexity as a barrier to prescribing the right drug for the patient.